Second-line therapy with gefitinib in combination with docetaxel for advanced non-small cell lung cancer: a phase II randomized study

2007 ◽  
Vol 2 (2) ◽  
pp. 63-71
Author(s):  
G. Robinet ◽  
F. Barlesi ◽  
P. Fournel ◽  
H. Berard ◽  
R. Corre ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Randomized Study ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Therapy ◽  
Line Therapy

Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancer

Lung Cancer ◽  
2009 ◽  
Vol 64 (1) ◽  
pp. 60-65 ◽  
Author(s):  
Tim Eisen ◽  
Nick Thatcher ◽  
Serge Leyvraz ◽  
Wilson H. Miller ◽  
Felix Couture ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Therapy ◽  
Line Therapy

A multi-center phase II study of weekly topotecan as second-line therapy for small cell lung cancer

Lung Cancer ◽  
2007 ◽  
Vol 57 (1) ◽  
pp. 84-88 ◽  
Author(s):  
Chirag Shah ◽  
Neal Ready ◽  
Michel Perry ◽  
Jeffrey Kirshner ◽  
Ajeet Gajra ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Therapy ◽  
Line Therapy

scholarly journals Phase II Trial of S-1 as Second-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer

2011 ◽  
Vol 6 (4) ◽  
pp. 790-795 ◽  
Author(s):  
Ramaswamy Govindan ◽  
Daniel Morgensztern ◽  
Michael D. Kommor ◽  
Roy S. Herbst ◽  
Paul Schaefer ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Therapy ◽  
Line Therapy

Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer

Lung Cancer ◽  
2004 ◽  
Vol 44 (2) ◽  
pp. 231-239 ◽  
Author(s):  
Giovanni Luca Ceresoli ◽  
Vanesa Gregorc ◽  
Stefano Cordio ◽  
Katia Bruna Bencardino ◽  
Stefano Schipani ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Therapy ◽  
Line Therapy

P-3 A phase II trial of the combination of temozolomide and irinotecan as second-line therapy for patients with non-small cell lung cancer

Lung Cancer ◽  
2003 ◽  
Vol 41 ◽  
pp. S91-S92
Author(s):  
Jerome D. Winegarden ◽  
Charles M. Rudin ◽  
Ann M. Mauer ◽  
Philip Hoffman ◽  
Livia Szeto ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Therapy ◽  
Line Therapy

scholarly journals Phase II Multicenter Trial of Voreloxin as Second-Line Therapy in Chemotherapy-Sensitive or Refractory Small Cell Lung Cancer

2011 ◽  
Vol 6 (2) ◽  
pp. 384-386 ◽  
Author(s):  
Lee M. Krug ◽  
Jeffrey Crawford ◽  
David S. Ettinger ◽  
Geoffrey I. Shapiro ◽  
David Spigel ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Multicenter Trial ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Therapy ◽  
Line Therapy
Sign in / Sign up

Export Citation Format

Share Document